Keywords: Sanofi-Aventis, Metabolex, Diabetes portfolio, MBX-2982, GLP-1

Sanofi-Aventis to expand diabetes portfolio in $375 million deal for Metabolex products

Article | 28 June 2010

Print This

Announcing a second major licensing deal in the same week, French drug major Sanofi-Aventis last Friday entered into a global ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in